iShares Genomics Immunology and Healthcare ETF
IDNA
3 hedge funds and large institutions have $20.5M invested in iShares Genomics Immunology and Healthcare ETF in 2019 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
206% more capital invested
Capital invested by funds: $6.68M → $20.5M (+$13.8M)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
25% less funds holding
Funds holding: 4 → 3 (-1)
67.7% less ownership
Funds ownership: 159.59% → 91.89% (-68%)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$16.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$880K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$583 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
BlackRock
New York
| $20.1M | +$16.4M | +620,000 | +310% |
|
2
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $359K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $2K | -$583 | -22 | -24% |
|
|
4
Jane Street
New York
| – | -$880K | -32,391 | Closed |
|
IDNA Hedge Fund Activity: Q3 2019 in Review
3 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in iShares Genomics Immunology and Healthcare ETF (IDNA) for Q3 2019, worth a combined $20.5M — up 206% from $6.68M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of IDNA and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was BlackRock, adding an estimated $16.4M. The largest seller was Jane Street, exiting entirely with an estimated $880K sold.
- 3 institutional investors held iShares Genomics Immunology and Healthcare ETF (IDNA) as of Q3 2019, down from 4 in Q2 2019.
- Funds reported $20.5M of iShares Genomics Immunology and Healthcare ETF stock for Q3 2019, up 206% quarter-over-quarter.
- 0 funds opened new iShares Genomics Immunology and Healthcare ETF positions in Q3 2019 and 1 closed out, a net change of -1 holder.
- The largest iShares Genomics Immunology and Healthcare ETF buyer in Q3 2019 was BlackRock, an estimated $16.4M added.
- The largest iShares Genomics Immunology and Healthcare ETF seller in Q3 2019 was Jane Street, an estimated $880K sold.
Based on aggregated 13F filings for Q3 2019.